from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3765c/tcrX

LFCtreatmentdescriptionclass of inhibitor

-0.355

Amikacinug/mL Amikacintranslation

-0.202

Cap5-10ug/mL Capreomycintranslation

-0.084

Rox10-50 ug/mL Roxithromycintranslation

-0.240

SM2-5 ug/mL Streptomycintranslation

1.178

Tet5-10 ug/mL Tetracyclinetranslation

-0.030

Rif0.2-5ug/mL Rifampicintranscription

-1.288

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.112

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.671

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.268

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.452

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.365

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.246

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.973

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.607

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.693

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.417

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.042

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.592

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.376

KCN5-20 ug/mL Potassium cyaniderespiration

0.197

NaN30.2-2 mM Sodium aziderespiration

0.470

Nigericin50 uM Nigericinrespiration

1.628

TRC10-150 ug/mL Triclosanrespiration

2.324

TRZ10-25 ug/mL Thioridazinerespiration

-0.921

Valinomycin0.5-10 uM Valinomycinrespiration

-0.296

ZnSO42 mM ZnSO4respiration

0.266

menadione6-10 ug/mL Menadionerespiration

-0.746

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.344

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.160

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.133

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.230

NRP_1Non-replicating persistence stage 1dosRassociated

0.045

Amp0.2mg/mL AmpicillincellWall

0.259

Cephalexin20-100 ug/mL CephalexincellWall

-0.508

Cerulenin0.32-5 ug/mL CerulenincellWall

0.116

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.011

EMB10-20 ug/mL EthambutolcellWall

0.087

Eta12-40 ug/mL EthionamidecellWall

0.449

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.689

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.611

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.944

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.460

BZA0.12 mg/mL BenzamidearomaticAmides

0.308

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.257

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.021

H2O24 mM hydrogen peroxideDNAdamaging

-0.602

Levo10 ug/mL LevofloxacinDNAdamaging

-0.854

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.903

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.245

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.776

UVUV-irradiationDNAdamaging

-0.101

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.775

Antimycin12.5-50 ug/mL Antimycin A?

0.256

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.721

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.646

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.093

PA8240.2-2 ug/mL PA-824?

-0.095

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.455

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.078

Verapamil50 uM Verapamil?

0.082

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.240

methoxatin10-20 ug/mL Methoxatin?